Elk Creek Partners’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
$5.98M Buy
509,174
+46,600
+10% +$547K 1.03% 36
2019
Q4
$10.9M Sell
462,574
-163,062
-26% -$3.83M 1.25% 27
2019
Q3
$11.6M Sell
625,636
-42,604
-6% -$788K 1% 40
2019
Q2
$12.4M Buy
+668,240
New +$12.4M 0.93% 39